Purpose: End-to-end testing with quality assurance (QA) phantoms for deformable dose accumulation and real-time image-guided radiotherapy (IGRT) has recently been recommended by American Association of Physicists in Medicine (AAPM) Task Groups 132 and 76. The goal of this work was to develop a deformable abdominal phantom containing a deformable three-dimensional dosimeter that could provide robust testing of these systems.
| INTRODUCTION
Patient motion can reduce the precision of external beam radiotherapy (EBRT), resulting in decreased target coverage and irradiation of nearby healthy structures. This motion can be especially detrimental in the thoracic and abdominal regions of the body, where translational motion and deformation can be on the order of several centimeters. [1] [2] [3] [4] Image-guided radiation therapy (IGRT) has improved the precision of radiotherapy by using different imaging systems to reduce interfractional and intrafractional motion uncertainties. Interfractional motion is monitored during treatment using daily patient imaging data and deformable dose accumulation algorithms. By applying deformable image registration (DIR), the dose each day is deformed to the original patient imaging data that were used to plan the initial treatment. 5 Daily dose maps are used to estimate the delivered cumulative dose distribution during the course of the treatment and assist clinicians in making informed decisions about the possible adaptations to a patient treatment course. 6, 7 Furthermore, real-time motion management techniques have been developed to account for intrafractional motion during each fraction resulting from respiratory motion, cardiac motion, peristalsis, etc. During delivery, the treatment is adapted to account for the motion of the target by either gating or tracking the treatment beam. 8, 9 Numerous imaging modalities have been utilized to monitor target motion including optical surface tracking, 10, 11 magnetic resonance imaging (MRI) guidance, 12, 13 ultrasound guidance, [14] [15] [16] and fluoroscopy. 17, 18 Both interfractional and intrafractional motion management strategies have led to the reduction of treatment margins used for a variety of tumor types seen clinically. 19 Clinical implementation of motion management systems requires that they first be validated through measurement. American Association of Physicists in Medicine Task Groups 76 and 132, which discuss respiratory motion management and image registration algorithms in radiotherapy, both recommend end-to-end testing of these systems using quality assurance (QA) phantoms. 20, 21 Robust testing of these systems requires a phantom that is able to simulate translational motion and deformation, be compatible with a variety of imaging modalities, and be reusable for multiple experiments. Ideally, these phantoms would also provide three-dimensional (3D) dosimetry, and steps toward the clinical implementation of deformable 3D dosimetry have been made. DEFGEL is a deformable normoxic polyacrylamide gel (nPAG) dosimeter contained within a latex membrane initially proposed Yeo et al. that has been proven by previous work to be well suited for 3D deformable dosimetry. 22 The dosimeter can be irradiated in a deformed state and read out in its original, undeformed state, allowing for the comparison of deformed dose calculations by deformable dose accumulation algorithms to physical measurement. Furthermore, this deformability allows for realistic dynamic deformation of a target during the test of real-time IGRT systems. 23 Other deformable dosimeters have been developed specifically for the testing of deformable dose accumulation algorithms, some examples being Presage-Def, FlexyDos3D, and the incorporation of normoxic methacrylic acid gel (nMAG) in lowdensity polyethylene containers (LDPE). [24] [25] [26] However, none of these dosimeters have been incorporated into fully deformable phantoms.
To the best of our knowledge, no phantom exists that includes all of these aforementioned features required to adequately provide 
| MATERIALS AND METHODS

2.A | Deformable abdominal phantom development
The phantom apparatus illustrated in Fig. 1 dosimeter to represent a liver tumor, which will be discussed further in following sections. An example axial slice of a CT of the second phantom is shown in Fig. 2 .
The programmable motion stage utilized in this apparatus was the surrogate-axis motion stage of the Washington University 4D
Phantom. 32 The motion stage was fully programmable and can be F I G . 1. a) Rendering and b) axial cross section of the deformable abdominal phantom that was developed. The phantom platform features a programmable motion stage and plunger apparatus to drive motion, a deformable phantom section with low-density organ sections, and a cavity for containing a removable deformable 3D dosimeter. 3D, three-dimensional.
Axial slice of a CT image of the PVCP abdominal phantom. PVCP, polyvinyl chloride plastisol.
2.B | Deformable 3D dosimeter
A DEFGEL nPAG dosimeter encased in a PVCP shell was paired with the abdominal phantom. The DEFGEL was fabricated using the materials, heating methods, and mixing techniques described by Yeo et al. 22 The gel was injected into deformable PVCP shells.
The PVCP shells were fabricated using an acrylic outer ring and a 3D-printed insert to create the shape of the inner cavity 
2.C | Static irradiation test
Measurements of static irradiation conditions using the deformable dosimeter in the first phantom were compared to the calculated dose distribution in Eclipse Virtual Water™ (Med-Cal Inc., Verona, WI) phantom, and resulted in a 98.0% γ pass rate for 3%/3 mm criteria.
After irradiation, the dosimeters were allowed to polymerize overnight and were imaged using MRI with a GE SIGNA TM 3T PET/ MRI (GE Healthcare, Waukesha, WI 
2.D | Static deformation test
The effects of static deformation on the dose distributions were measured by the nPAG dosimeters in the second, higher contrast deformable phantom apparatus. The purpose of the investigation was to show the apparatus' ability to measure the effects of static deformation for the purpose of testing deformable dose accumulation algorithms. Five dosimeters were created for this experiment and each was imaged with CT in phantom. One dosimeter was used to calibrate the nPAG batch dose response with a four-field treatment plan similar to that of the static irradiation test, except with a maximum dose of 14 Gy, and a volumetric modulated arc therapy (VMAT) liver treatment plan was created for the remaining dosimeters. In this case, the treatment was scaled to a 3 Gy target dose, as opposed to the previous 12 Gy target dose to avoid dosimeter response saturation over multiple fraction deliveries. Delivery QA was performed using the same method as the static irradiation test, and resulted in a γ pass rate of 99.5% for 3%/3 mm criteria.
The first dosimeter had no additional deformation placed on it and was irradiated with a single treatment fraction serving as a base- formed to its original shape. All dosimeters were MR imaged and analyzed after irradiation using the procedure described for the static irradiation benchmarking.
2.E | Dynamic deformation test
The second phantom apparatus was used to study the effects of dynamic motion and deformation during irradiation and the influence of beam gating on a treatment delivery. During irradiation, the apparatus was set to dynamically move and deform while measuring dose for the testing of real-time IGRT systems. Due to the gating limitations of the Clinac 21EX Linac research linac used for this work, the VMAT treatments that were originally planned to represent liver treatments were replanned and delivered as IMRT plans. Delivery QA was performed using the same method as the static irradiation test, and resulted in a γ pass rate of 100.0% for 3%/3 mm criteria. 
| RESULTS
3.A | Static irradiation test
An example of an axial slice of the planned dose distribution and measured distribution in one of the gel dosimeters is shown in Each dosimeter irradiated with the liver SBRT plan was compared to its planned dose distribution using 3D γ-analysis 38,39 with 3%/5 mm and 5%/5 mm criteria. The 5 mm distance-to-agreement (DTA) criterion was chosen so that the DTA criterion would be larger than the largest dimension of the dose map voxel size, 3 mm.
The 5% dose difference was used to account for the 5% estimated k = 1 uncertainty of the gel dosimeter. 40 Pass rates were calculated for the full volume and the central slice with a dose threshold of 20% of the maximum planned dose on both the measured and planned dose maps to remove low-dose regions and regions of oxygen inhibition within the dosimeter and planned low-dose regions.
The average pass rates and standard deviations for each analysis are shown in Table 1 . Table 2 were calculated with a dose threshold meant to include points where either the baseline dose map or the deformed dosimeter dose map displays a dose over 20%.
3.B | Static deformation test
3.C | Dynamic deformation test
The central coronal slices of the isodose maps of each dosimeter are shown in Fig. 10 . Without beam gating, dynamic deformation measurements revealed a shift toward the site of deformation in the bottom right corner of the isodose map and widening and blurring of the high-dose region. The shift toward the site of deformation was not present when beam gating was used during the treatment. Figure 11 shows an IEC defined y-profile through each of the dosimeters, which further illustrates the shift of the ungated dosimeter and the blurring measured from both dosimeters. The undeformed dosimeter was compared to the planned dose distribution and was found to have a 96.4% pass rate for 3%/5 mm criteria and a 97.4% pass rate for 5%/5 mm criteria. Example central coronal slices of the γ maps of the comparison of the dynamically deformed dosimeters to the undeformed dosimeter are shown in Fig. 12 , and the pass rates are shown in Table 3 . γ pass rates were calculated using the same 20% threshold as the static deformation experiment.
| DISCUSSION
This work presents a deformable abdominal phantom featuring a deformable 3D gel dosimeter developed for the testing of dose accumulation algorithms and real-time motion management systems.
PVCP has many advantages as an anthropomorphic phantom material due to its deformability and high degree of customizability for multimodal imaging. The composition of phantom materials can be modified to enhance contrast in CT and MRI or alter the radiological properties in order to accurately represent specific organs of the body. With the addition of an imaging window in the phantom apparatus and an ultrasonic scatter such as graphite mixed in with the PVCP, the phantom can be used with ultrasound imaging and will have a tissue-like appearance. 28 These properties of the PVCP material allow for a more versatile phantom that can aid in the testing of a variety of systems that utilize imaging as a motion management method. Also, the addition of the fully programmable motion-driving system allows for the use of realistic motion traces during treatment including simple static deformations.
The pairing of a deformable nPAG dosimeter with the deformable phantom apparatus allows for robust testing of different suggest that the majority of discrepancies occurred in the penumbra regions in the slice direction. Therefore, it is important to either choose an MRI slice direction that has a low-dose gradient, or if this is not possible, choose a slice direction in a direction of lower interest. This also means that one should not select a slice direction in the direction of motion when motion is incorporated. With these guidelines taken into account, the measurements of the nPAG dosimeters placed in-phantom during irradiation were shown to be reliable and match well with planned dose distributions.
Static deformation created by the motion stage plunger is consistent with shifts toward deformation sites shown by previous work in deformable 3D dosimetry. 22 In the case of the dosimeters irradiated with a single fraction, the deformation resulted in distinct shifting in the higher isodose levels. Specifically, the plunger pushed the medial side of the dosimeter (the right-hand side of Fig. 7) , resulting in the section of gel closer to the plunger to be pushed into the beam, while a section of the gel further from the plunger was pushed out of the beam. When the gel is returned to its original shape at which the treatment was planned at, this push into and out of the irradiated region appears as a shift of the dose distribution approximately equal to the magnitude of deformation on the cranial edge of the phantom, as shown by the profiles in Fig. 8 . The dosimeter irradiated with three fractions showed the effects of multiple deformations over the course of treatment, which caused a blurring of the cumulative dose over a large volume. This blurring can be observed in Fig. 8 that shows a step-like nature in the profile due to the three distinct deformation states the dosimeter was irradiated in. This case simulates a patient treatment where patient anatomy may show slight day-to-day shifts and deformations.
The phantom apparatus showed through these measurements the ability to simulate and directly measure the effects of interfractional variations. This suggests that the apparatus could be used in the future for the comparison to the calculations of the deformable dose accumulation algorithms which monitor these day-to-day variations through γ-analysis and other metrics. During the static deformation measurements, the increase from a 1 cm deformation to a 2 cm deformation resulted in a large shift in the dose distribution, which caused the γ pass rate to decrease, indicating that increasing shifts and deformations can be a detriment on plan delivery quality.
The γ-analyses of the three-fraction dosimeter showed that the blur- 
